Page 5 - ARTFILLER PROFESSIONAL BROCHURE

> LEICHT ZU INJIZIEREN

FÜR EINE INDIVIDUELLE
KORREKTUR

>
SICHERHEIT UND
LANGFRISTIG,
ANHALTENDE
WIRKUNG ÜBER 18
MONATE (4, 5, 6)

> KOLLEKTION, AKTIVER

REGENERATIVER
FILLER (1, 2, 3)

(1) Trevidic P, Andre P, Benadiba L, Deutsch JJ, Galatoire O, Garcia P, Grand-Vincent A, Boisnic S, Kerihuel JC, Salomon C. Prospective, Split-Face, Randomized,
Long-Term Blinded Objective Comparison of the Performance and Tolerability of Two New Hyaluronic Acid Fillers. Dermatol Surg. 2017 Dec;43(12):1448-1457. doi:
10.1097/DSS.0000000000001193. Erratum in: Dermatol Surg. 2018 Aug;44(8):1158. PMID: 28595250. (2) Chen R, Yang W, Sun J, Liu Y, An Q, Zhang F, Bai Z, Luan Q.
Triple Cross-Linked Hyaluronic Acid Based on TRI-HYAL technique Has More Durable Effect on Dermal Renewal. Clin Cosmet Investig Dermatol. 2022;15:691-701
®
https://doi.org/10.2147/CCID.S362785. (3) Nadra K, André M, Marchaud E, Kestemont P, Braccini F, Cartier H, Kéophiphath M, Fanian F. A hyaluronic acid-based
filler reduces lipolysis in human mature adipocytes and maintains adherence and lipid accumulation of long-term differentiated human preadipocytes. J Cosmet
Dermatol. 2021 May;20(5):1474-1482. doi: 10.1111/jocd.13794. Epub 2020 Nov 4. PMID: 33150734; PMCID: PMC8246837. (4) Trevidic P, Andre P, Benadiba L, Deutsch
JJ, Galatoire O, Garcia P, Grand-Vincent A, Boisnic S, Salomon C, Fanian F. Objective 18-month Comparison of the Tolerability of 2 Dermal Fillers Formulated
with TRI-HYAL Technology. Plast Reconstr Surg Glob Open. 2020 Dec 9;8(12):e3274. doi: 10.1097/GOX.0000000000003274. PMID: 33425589; PMCID: PMC7787280.
®
(5) Braccini F, Fanian F, Garcia P, Delmar H, Loreto F, Benadiba L, Nadra K, Kestemont P. Comparative clinical study for the efficacy and safety of two different
hyaluronic acid-based fillers with TRI-HYAL versus Vycross technology: A long-term prospective randomized clinical trial. J Cosmet Dermatol. 2023 Feb;22(2):473-
®
485. doi: 10.1111/jocd.15200. Epub 2022 Jul 19. PMID: 35770300; PMCID: PMC10084174. (6) Ehlinger-David A, Gorj M, Braccini F, Loreto F, Grand-Vincent A, Garcia P,
Taieb M, Benadiba L, Catoni I, Mathey ER, Deutsch JJ, Bahadoran P, Vincent T, David M, Cartier H, Nadra K, Moellhoff N, Fanian F. A prospective multicenter clinical
trial evaluating the efficacy and safety of a hyaluronic acid-based filler with TRI-HYAL Technology in the treatment of lips and the peri-oral area. J Cosmet Dermatol.
®
2023 Feb;22(2):464-472. doi: 10.1111/jocd.15169. Epub 2022 Jul 31. PMID: 35718985; PMCID: PMC10087550.